1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Heart Valve Disease Global Clinical Trials Review, H2, 2014

Heart Valve Disease Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 71 pages

Heart Valve Disease Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Heart Valve Disease Global Clinical Trials Review, H2, 2014" provides data on the Heart Valve Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Valve Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Heart Valve Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Heart Valve Disease Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Heart Valve Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Heart Valve Disease to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Heart Valve Disease to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Heart Valve Disease 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Heart Valve Disease Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Edwards Lifesciences Corporation 33
Clinical Trial Overview of Edwards Lifesciences Corporation 33
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Sorin S.p.A. 35
Clinical Trial Overview of Sorin S.p.A. 35
CryoLife, Inc. 36
Clinical Trial Overview of CryoLife, Inc. 36
C. H. Boehringer Sohn AG and Co. KG 37
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 37
Avant Immunotherapeutics, Inc 38
Clinical Trial Overview of Avant Immunotherapeutics, Inc 38
Armetheon, Inc. 39
Clinical Trial Overview of Armetheon, Inc. 39
A. Menarini Industrie Farmaceutiche Riunite Srl 40
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 40
Clinical Trial Overview of Top Institutes / Government 41
National Heart, Lung, and Blood Institute 41
Clinical Trial Overview of National Heart, Lung, and Blood Institute 41
Yonsei University 42
Clinical Trial Overview of Yonsei University 42
Oslo University Hospital 43
Clinical Trial Overview of Oslo University Hospital 43
Meshalkin Research Institute of Pathology of Circulation 44
Clinical Trial Overview of Meshalkin Research Institute of Pathology of Circulation 44
Xijing Hospital 45
Clinical Trial Overview of Xijing Hospital 45
Boston Children's Hospital 46
Clinical Trial Overview of Boston Children's Hospital 46
Erasmus MC 47
Clinical Trial Overview of Erasmus MC 47
Konkuk University Medical Center 48
Clinical Trial Overview of Konkuk University Medical Center 48
Assistance Publique - Hopitaux de Paris 49
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 49
Duke University 50
Clinical Trial Overview of Duke University 50
Five Key Clinical Profiles 51
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Heart Valve Disease Therapeutics, Global, Clinical Trials by Region, 2014* 7
Heart Valve Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Heart Valve Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Heart Valve Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Heart Valve Disease Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Heart Valve Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Heart Valve Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Heart Valve Disease Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Heart Valve Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Heart Valve Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Heart Valve Disease Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Heart Valve Disease Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Heart Valve Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Heart Valve Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Heart Valve Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Heart Valve Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Heart Valve Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Edwards Lifesciences Corporation, 2014* 33
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 34
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sorin S.p.A., 2014* 35
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by CryoLife, Inc., 2014* 36
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 37
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Avant Immunotherapeutics, Inc, 2014* 38
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Armetheon, Inc., 2014* 39
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014* 40
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 41
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 42
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2014* 43
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Meshalkin Research Institute of Pathology of Circulation, 2014* 44
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2014* 45
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 46
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 47
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Konkuk University Medical Center, 2014* 48
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 49
Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 50

List of Figures
Heart Valve Disease Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Heart Valve Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Heart Valve Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Heart Valve Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Heart Valve Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Heart Valve Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Heart Valve Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Heart Valve Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Heart Valve Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Heart Valve Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Heart Valve Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Heart Valve Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Heart Valve Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Heart Valve Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Heart Valve Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.